Sacituzumab Govitecan for Advanced Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Squamous Cell Carcinoma Interventions: Drug: Sacituzumab govitecan Sponsors: National Taiwan University Hospital; Gilead Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Esophagus Cancer | Hospitals | Research | Skin Cancer | Squamous Cell Carcinoma | Taiwan Health